Literature DB >> 16789617

McCune-Albright syndrome: clinical picture and natural history in children and adolescents.

Thomas M K Völkl1, Helmuth G Dörr.   

Abstract

The classical triad of McCune-Albright syndrome (MAS) consists of polyostotic fibrous dysplasia (FD), skin hyperpigmentation (café-au-lait spots), and endocrine dysfunction, frequently seen in females as precocious puberty. Patients with MAS display mosaicism of activating somatic mutations of the alpha-subunit of Gs. Thus, the clinical presentation of each individual is dependent on the particular distribution of affected cells, causing a broad spectrum of endocrine and non-endocrine manifestations. Typical endocrinopathies are precocious puberty, hyperthyroidism, growth hormone excess, hyperprolactemia, and hypercortisolism. The onset of these manifestations is usually during infancy and childhood. Since specific treatment is required, the prognosis depends on the severity of each individual endocrine manifestation. Additionally, there are non-endocrine manifestations, such as fibrous dysplasia of bone (FD), renal phosphate wasting, and skin hyperpigmentation, i.e. café-au-lait spots. FD, mostly polyostotic, causes fractures needing surgical and orthopedic treatment. Since previous studies have suggested the overall prognosis of patients with McCune-Albright syndrome to be non-fatal, recent data have drawn our attention to non-endocrine affections, including hepatobiliary dysfunction and cardiac disease, which are probably an important risk factor for early death. In summary, the clinical picture in MAS is related to its mosaic nature, i.e. any cell, tissue and organ in any site of the body could be affected to varying degrees, ranging from one or two mild clinical signs with excellent long-term prognosis to a severe life-threatening multiorgan disease.

Entities:  

Mesh:

Year:  2006        PMID: 16789617     DOI: 10.1515/jpem.2006.19.s2.551

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  11 in total

1.  Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to McCune-Albright Syndrome in a Child: A Case Report.

Authors:  Ana Luiza Andrade Aragão; Ivani Novato Silva
Journal:  Int J Pediatr Endocrinol       Date:  2010-09-21

2.  Anterior pituitary adenomas: inherited syndromes, novel genes and molecular pathways.

Authors:  Paraskevi Xekouki; Monalisa Azevedo; Constantine A Stratakis
Journal:  Expert Rev Endocrinol Metab       Date:  2010-09-01

3.  Toxic Thyroid Adenoma in McCune-Albright Syndrome.

Authors:  Sahana Shetty; Ron Thomas Varghese; Nylla Shanthly; Thomas V Paul
Journal:  J Clin Diagn Res       Date:  2014-02-03

4.  A non-classic form of McCune Albright syndrome with different presentations and review of the literatures.

Authors:  Alireza Navabazam; Fatemeh Owlia; Mohammad Hassan Akhavan Karbassi; Roqayeh Hakimian
Journal:  Caspian J Intern Med       Date:  2021

Review 5.  Sexual precocity and its treatment.

Authors:  DeAnna B Brown; Lindsey A Loomba-Albrecht; Andrew A Bremer
Journal:  World J Pediatr       Date:  2013-05-16       Impact factor: 2.764

6.  Eight-year follow-up of a girl with McCune-Albright syndrome.

Authors:  Zehra Aycan; Aşan Önder; Semra Çetinkaya
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011-02-23

7.  Etiology and therapeutic outcomes of children with gonadotropin-independent precocious puberty.

Authors:  Eungu Kang; Ja Hyang Cho; Jin-Ho Choi; Han-Wook Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2016-09-30

8.  Allergic manifestations and cutaneous histamine responses in patients with McCune Albright syndrome.

Authors:  Jill D Jacobson; Angela L Turpin; Scott A Sands
Journal:  World Allergy Organ J       Date:  2013-05-01       Impact factor: 4.084

9.  Regulation of anti-Müllerian hormone (AMH) in males and the associations of serum AMH with the disorders of male fertility.

Authors:  Hui-Yu Xu; Hong-Xian Zhang; Zhen Xiao; Jie Qiao; Rong Li
Journal:  Asian J Androl       Date:  2019 Mar-Apr       Impact factor: 3.285

10.  McCune Albright Syndrome.

Authors:  Nada Jibbe; Atieh Jibbe; Anand Rajpara
Journal:  Kans J Med       Date:  2020-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.